equine
assay data sheet
Equine
Herpesvirus Type II (EHV-2)
Test code: S0072
Test name: Qualitative detection
of Equine Herpesvirus Type II by polymerase chain reaction
Equine herpesvirus type II (EHV-2) is a DNA
virus belonging to the gammaherpesvirus family. This virus
infects B cells and is related to other lymphotropic herpesviruses
such as Epstein-Barr virus (EBV, which causes glandular fever)
and human herpesvirus type 8 (HHV-8), also known as Kaposi's
sarcoma herpesvirus.
EHV-2 is highly prevalent (approaching 100%)
in horse populations (Borchers et al., 1999) and has been
proposed to cause, or to be a predisposing factor for, a number
of distinct syndromes. These include “loss of performance”,
conjunctivitis (Kershaw et al., 2001) and respiratory tract
disease. EHV-2 has also been suggested as a possible transactivating
factor triggering or exacerbating EHV-1 or EHV-4 reactivation
and disease. While the association of EHV-2 with particular
diseases is subject to debate, it is clear that this virus
has the potential to escape and subvert host immune responses.
Serological detection of EHV-2 is of limited
use to determine the re-activation of this herpes virus. EHV-2
can remain latent in affected animals while shedding at levels
adequate to infect other horses. Culture identification of
EHV-2 is slow and has low sensitivity. Molecular detection
of EHV-2 by PCR is the most sensitive, specific and accurate
tool in assessing the infectivity of an affected horse.
Utilities:
- Confirm the disease causing agent
- Shorten the time required to confirm a
clinical diagnosis of EHV-2 infection
- Ensure that horse populations are free
of EHV-2
- Early prevention of spread of this virus
- Minimize personnel exposure to this virus
- Safety monitoring of biological products
that derive from horses
References:
Slater, J. D., Borchers, K., Thackray, A. M. and Field, H.
J. (1994) The trigeminal ganglion is a location for equine
herpesvirus 1 latency and reactivation in the horse. J. Gen.
Virol. 75: 2007–2016.
Specimen requirements: 1
ml whole blood in EDTA (purple top) or ACD (yellow top) tube,
or nasopharyngeal swab, or bronchoalveolar lavage, or tissue,
shipped overnight at room temperature; or tissue shipped frozen.
For specimen types other than those listed
here, please call to confirm specimen acceptability and shipping
instructions.
For all specimen types, if there will be a
delay in shipping, or during very warm weather, refrigerate
specimens until shipped and ship with a cold pack unless more
stringent shipping requirements are specified. Frozen specimens
should be shipped so as to remain frozen in transit. See shipping
instructions for more information.
Turnaround time: 2 business
days
Methodology: Qualitative
PCR
Normal range: Nondetected